Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
The Cancer Research Institute is involved in the development of immunotherapy, the treatment at the centre of a recent successful global clinical trial ...
The topics such as cancer biomarker research; cancer immunotherapy; brain tumor; lung cancer; breast cancer; hepatobiliary cancer; CML; renal cell ...
... clinical benefits of GEN-1, its DNA-based immunotherapy, as a single agent in advanced platinum-resistant and recurrent ovarian cancer patients, ...
A study of oral pathogen Fusobacterium nucleatum, commonly found in the mouth, indicates that it can actually impede the body's immune system ...
Engineering a patient's own T-cells to express chimeric antigen receptors (CARs) has shown considerable promise as a cancer treatment. This alteration steers the immune cells to attack tumor cells, and has for example been used to drive leukemia into remission in trials. Here researchers are preparing a trial to test the use of CARs in targeting the brain cancer glioblastoma
One approach to targeting cancer cells for destruction is to employ viruses as the kill mechanism, coupled with antibodies that can discern the type of cell to kill. The ideal outcome is that viruses infect only cancer cells, multiply inside them, destroy the cells and burst out to seek more victims, and then die out when there are no more cancer cells to target. There are, as always, challenges along the way to attaining this result, however
A research team led by investigators from Mayo Clinic's campus in Jacksonville, Florida, and the University of Oslo, Norway, have identified a ...
Wei Zheng, M.D., Ph.D., co-leader of the Cancer Epidemiology Research ... with cancer of the breast, colon or rectum, prostate, lung, liver, pancreas, ...
Jacksonville, Florida - Cancer researchers at Mayo Clinic's campus in ... and breast cancer to prostate and pancreatic cancer,” says Dr. Copland.
Tambahkan Komentar